In a previous interview with Culture’s CEO and cofounder, Will Patrick, we explored the origins of...
In a previous interview with Culture’s CEO and cofounder, Will Patrick, we explored the origins of...
An interview with Satshabad Khalsa, a Software Engineer at Culture, about his career journey.
Data from an ongoing collaboration with Cytovance Biologics to rapidly optimize and scale...
One year after launching the company, Culture Biosciences’ co-founder and CEO, Will Patrick,...
revised December 2, 2022
Announcing the launch of additional graphing and data visualization...
Ranjan Patnaik, PhD, the Chief Technology Officer at The EVERY Company, sat down with us to discuss...
We spoke with Scott Franklin, PhD, Co-Founder and CSO at Checkerspot. Checkerspot is a synthetic...
We interviewed Darcy Prather, the co-founder and President of Kalion Inc. Kalion is working to...
Early stage biotech companies can now start running high-throughput bioreactor experiments faster.
revised December 2, 2022
Announcing a new dynamic graphing tool on our online analysis platform....
What could you achieve with more bioreactor capacity?
You’re no longer limited by the bioreactor capacity in your lab.
© Culture Biosciences. All rights reserved.